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miR-20a is an important member of the miR-17–92 cluster, and its real function in cervical cancer
cells is unknown. Our study demonstrated that miR-20a was upregulated in cervical cancer tissues.
Overexpression of miR-20a in cervical cancer-derived cell lines, HeLa and C-33A, enhanced long-
term cellular proliferation, migration and invasion, whereas inhibition of miR-20a suppressed those
functions. We also conﬁrmed that oncogenic TNKS2 is directly upregulated by miR-20a. Further-
more, suppression of TNKS2 expression could inhibit colony formation, migration and invasion of
cervical cancer cells. Therefore, we concluded that miR-20a can promote migration and invasion
of cervical cancer cells through the upregulation of TNKS2.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction worldwide. Several miRNAs, including miR-214 [9], miR-143MicroRNAs (miRNAs) are a group of non-coding RNAs with a size
of 21–24 nucleotides that have been reported to be oncogenes or tu-
mor suppressors [1,2]. miRNAs can play important roles in cell
growth, migration, invasion, and apoptosis. At present, the miR-
17-92 cluster (composed of miR-17-5p, miR-17-3p, miR-18a, miR-
19a, miR-20a, miR-19b, andmiR-92-1) has attracted much attention
following a series of observations linking these miRNAs to cancer
pathogenesis [3]. For instance, the overexpression of the miR-17-92
locus has been identiﬁed in lung cancer [4] and hepatocellular carci-
noma [5]. Similarly, miR-20a, an important member of the miR-17-
92 cluster, has been shown to be involved in the regulation of cell
proliferation in human lung cancer [4] and chronicmyeloid leukemia
[6]. Another study has recently indicated that miR-20a can also pro-
mote proliferation and invasion in ovarian cancer OVCAR3 cells [7].
Cervical cancer is a highly prevalent cancer that affects women
of different ages and backgrounds across the world [8]. It is the sec-
ond most common cause of cancer-related deaths in womenchemical Societies. Published by E
RNA-20a; TNKS2, Tankyrase
otide; EGFP, enhanced green
hate dehydrogenase; PARP,
g-Tai Road, Tianjin 300070,[10], miR-375 [11] and miR-23b [12], have been reported to be
deregulated in cervical cancer and may be related to the malignant
phenotypes of cervical cancer. However, the relationship between
miR-20a and cervical cancer is still unknown.
It is known that telomeres could promote the development of
cancer [13]. Tankyrase 2 (TNKS2), a new member of the human
telomere-associated poly (ADP-ribose) polymerase (PARP) family,
binds the telomere-binding protein TRF1 and protects the ends of
linear chromosomes [14]. Recent studies have shown that TNKS2
is upregulated in tumor cells and can increase telomere length
when overexpressed, which suggests that TNKS2 can promote tu-
mor progress and function as an oncogene [13,15]. Several reports
have shown that TNKS2 can be regulated by a host of associated
proteins, including TRF1 [14]. However, the reports to date have
not described a relationship between TNKS2 and miRNAs.
Here, we reveal that miR-20a induces cell migration and inva-
sion in human cervical cancer cells, including HeLa and C-33A cells.
In addition, TNKS2 is positively regulated by miR-20a and similarly
promotes migration and invasion in HeLa and C-33A cells.
2. Materials and methods
2.1. miRNA target prediction
The putative targets of miR-20a were predicted using the Target
Scan, PicTar, and miRanda algorithms.lsevier B.V. All rights reserved.
Table 1
Primers used in quantitative RT–PCR.
Name Sequence (50-30)
Pri-miR-20a-S 50-GCGAGATCTAGTTGTGCAAATCTATGC-30
Pri-miR-20a-AS 50-GGCGAATTCTAACCATAGAACAGTGTTC-30
TNKS2–30UTR-S 50-CGCGGATCCTGAAGGTATGGTCGATG-30
TNKS2–30UTR-AS 50-CGCGAATTCAATTTAGTACAGACAACCC-30
b-actin-S 50-CGTGACATTAAGGAGAAGCTG-30
b-actin-AS 50-CTAGAAGCATTTGCGGTGGAC-30
miR-20a RT primer 50-GTCGTATCCAGTGCAGGGTCCGAGGTGCACTG
GATACGACCTACCTG-30
miR-20a Forward primer 50-GCCCGCTAAAGTGCTTATAGTG-30
U6 RT primer 50-GTCGTATCCAGTGCAGGGTCCGAGGTGCACTG
GATACGACAAAATATGG-30
U6 Forward primer 50-TGCGGGTGCTCGCTTCGGCAGC-30
Reverse primer 50-CCAGTGCAGGGTCCGAGGT-30
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The human cervical cancer cell lines HeLa and C-33A cells were
maintained in RPMI1640 (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum, 100 IU/ml of penicillin and 100 lg/
ml of streptomycin. The cells were incubated at 37 C in a humid-
iﬁed chamber supplemented with 5% CO2.
2.3. Human tissue samples
Eighteen paired human cervical cancer tissues and adjacent
normal tissues from cervical cancer patients were obtained from
the Tumor Bank Facility of Tianjin Medical University Cancer Insti-
tute and the National Foundation of Cancer Research (TBF of TMU-
CIH and NFCR) with the patients’ informed consent. Histologically
all the biopsies were squamous cell carcinoma and the stages of
cancer were from IIa to III. The diagnoses of these samples were
veriﬁed by pathologists. Approval for this work was granted by
the Ethics Committee of Tianjin Medical University.
2.4. RNA preparation
Total RNA was extracted from cells or tissue samples using TRI-
zol reagent (Invitrogen, CA, USA) according to the manufacturer’s
instructions. For RNA integrity assessment, part of an RNA sample
was used for concentration and purity measurement (by A260 and
A280 spectrophotometry) and another part of the sample was run
on a 1.5% denaturing agarose gel stained with ethidium bromide. A
ratio of the absorbance at 260 and 280 nm (A260/280) of 1.8–2 is ac-
cepted. And the sharp, clear 28S and 18S rRNA bands and the 2:1
ratio (28S:18S) are the good indication that the RNA is completely
intact.
2.5. Quantitative reverse transcription–polymerase chain reaction
(RT–PCR)
Quantitative RT–PCR was performed to detect the relative tran-
script levels of miR-20a and TNKS2. Brieﬂy, a cDNA library was
generated using M-MLV reverse transcriptase (Promega, Madison,
WI) and oligo dT with 5 lg of extracted RNA, and this cDNA was
used for the ampliﬁcation of TNKS2 and b-actin (Paired primers
shown in Table 1). PCR was performed under the following condi-
tions: 94 C for 4 min followed by 40 cycles of 94 C for 1 min,
56 C for 1 min and 72 C for 1 min.
To detect the mature miR-20a level, a stem-loop RT–PCR assay
was performed using speciﬁc RT and PCR primers (Table 1). U6
snRNA was used as an endogenous control. Five micrograms of to-
tal RNA was reverse transcribed to cDNA with a speciﬁc RT primer
that can fold into a stem-loop structure. The PCR cycles were as fol-
lows: 94 C for 4 min followed by 40 cycles of 94 C for 30 s, 50 C
for 30 s and 72 C for 30 s. PCR was performed using the SYBR Pre-
mix Ex Taq Kit (TaKaRa, Madison, WI) according to the manufac-
turer’s instructions and analyzed using the 7300 RT–PCR system
(ABI). The relative expression levels of interest gene were calcu-
lated by the 244Ct method. All primers were purchased from
AuGCT Inc. (Beijing, China).
2.6. Cloning of miR-20a
Reverse transcription was performed using total RNA from HeLa
cells as a template and random hexamer as a primer. Pri-miR-20a
(the fragment containing the precursor of the miR-20a) was ampli-
ﬁed using the primers shown in Table 1 and then cloned into the
BamHI/EcoRI restriction sites of pcDNA3. The resulting construct
pcDNA3/pri-miR-20a (pri-miR-20a) was conﬁrmed by DNA
sequencing.2.7. Western blot
Cells were washed with PBS and lysed at 4 C for 30 min by RIPA
buffer. Cell extracts were cleared by centrifugation at 12,000g for
10 min at 4 C, and the supernatant was used for Western blot
analyses. All proteins were resolved on a 10% SDS denaturing poly-
acrylamide gel and then transferred onto a nitrocellulose mem-
brane. Membranes were incubated with blocking buffer for
90 min at room temperature and were then incubated overnight
at 4 C with an anti-TNKS2 antibody (Sigma, St. Louis, MO, USA)
or anti-glyceraldehyde phosphate dehydrogenase (GAPDH) anti-
body (Tianjin Saier Biotech, Tianjin, China) prepared in blocking
buffer. The membranes were washed and incubated with a horse-
radish peroxidase (HRP)-conjugated secondary antibody. Protein
expression was assessed by enhanced chemiluminescence and
exposure to chemiluminescent ﬁlm. Lab Works Image Acquisition
and Analysis Software (UVP) were used to quantitate band
intensities.
2.8. Fluorescent reporter assay
The 30UTR of TNKS2 with the miR-20a binding site or with a
mutated miR-20a binding site was ampliﬁed using PCR and cloned
into the pcDNA3/EGFP vector using BamHI/EcoRI restriction sites
[16]. The resulting vectors are named pcDNA3/EGFP-TNKS2–30UTR
or pcDNA3/EGFP-TNKS2–30UTR mut. A separate RFP expression
vector, pDsRed2-N1 (Clontech, Mountain View, CA) was used for
normalization. The following vectors were cotransfected into cells:
those containing the EGFP reporter vector alone, with pcDNA3/pri-
miR-20a, or bearing ASO-miR-20a. PcDNA3/EGFP, pcDNA3 or ASO-
NC were used as control vectors. The intensities of EGFP and RFP
ﬂuorescence were detected with the F-4500 Fluorescence Spectro-
photometer (Hitachi, Tokyo, Japan).
2.9. Cell transfection
HeLa cells (4  105 cells per well) were seeded into 6-well
culture plates and grown overnight. Then cells were transfected
with miR-20a expression vector (pri-miR-20a, 4 lg each well) or
miR-20a antisense oligonucleotides (ASO-miR-20a, 400 lmol).
For C-33A cells, 1  106 cells per well were seeded into 6-well
culture plates. 5 lg pri-miR-20a or 500 lmol ASO-miR-20a was
transfected. The plasmid pcDNA3 and the non-relative sequence
(ASO-NC) were used for negative control. Transfection was per-
formed with Lipofectamine 2000 Reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. 24 h post-transfec-
tion, cells were used for cell viability, cell colony formation and
in vitro migration and invasion assays.
Fig. 1. High miR-20a expression levels do not affect HeLa cell and C-33A cell viability, but can effect colony formation in vitro. (A–B) The expression level of miR-20a
following transfection of pri-miR-20a or ASO- miR-20a in HeLa and C-33A cells. In HeLa cells or C-33A cells transfected with pri-miR-20a, the mature miR-20a level was
signiﬁcantly increased, whereas the mature miR-20a level was signiﬁcantly decreased when cells transfected with ASO-miR-20a. (C–D) HeLa or C-33A cells were transfected
with either pri-miR-20a or ASO-miR-20a. HeLa cell viability was detected by the MTT assay at 48 h (P > 0.05). (E–F) HeLa or C-33A cells were transfected with either pri-miR-
20a or ASO-miR-20a in 48-well plates. The cells were then seeded in 12-well plates. For the colony formation assay, the cells were stained with crystal violet. Representative
pictures of these colonies are shown. The number of colonies was counted on the twelfth day (HeLa cells) or the ﬁfteenth day (C-33A cells) after seeding.
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Twenty-four hours after transfection, cells were seeded in 96-
well plates at either 6  103 cells/well (HeLa cells) or 15 
103 cells/well (C-33A cells). The MTT assay was used to measure
cell viability at 48 and 72 h after transfection as previously de-
scribed [16].
2.11. Colony formation assay
Cells were counted and seeded (300 cells/well) in 12-well plates
(in triplicate). Fresh culture medium was replaced every 3 days.Colonies were counted only if they contained more than 50 cells,
and the number of colonies was counted either 12 days (HeLa cells)
or 15 days (C-33A cells) after seeding. The cells were stained using
crystal violet. Colony formation was quantiﬁed using the colony
formation number.
2.12. In vitro migration and invasion assays
In vitro cell invasion and migration assays were performed
using transwell chambers (pore size of 8 lM; Costar, Corning,
NY) with or without 2 mg/ml Matrigel (Clontech, Mountain View,
CA). Transfected cells were resuspended in serum-free medium,
Fig. 2. miR-20a promotes migration and invasion of cervical cancer cells in vitro. (A) Transwell migration assays were performed with HeLa cells transfected with either miR-
20a and control vector or ASO-miR-20a and ASO-NC. The quantitation of ﬁve randomly selected ﬁelds is shown at the top and representative images are shown at the bottom.
Transwell assays without Matrigel demonstrated that miR-20a signiﬁcantly promoted the migration of HeLa cells when compared to the control vector groups. The results
were consistent when knockdown of miR-20a was performed. (B) Overexpression and knockdown of miR-20a were also performed in C-33A cells with similar effects on their
migration ability. (C) Transwell assays with Matrigel demonstrated that miR-20a overexpression signiﬁcantly inhibited the invasion of HeLa cells when compared with the
control vector groups. The results were consistent when miR-20a was knocked down. (D) Likewise, the overexpression and knockdown of miR-20a in C-33A cells had similar
effects on cellular invasion.
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upper chamber. Complete medium was added to the bottom wells
of the chambers. For the screen, cells that had not migrated after
either 20 h (HeLa cells) or 36 h (C-33A cells) were removed and
cells that were adhered to the lower membrane of the inserts were
counted, as previously described [9]. Images of three different
ﬁelds were taken. The mean of triplicate assays for each experi-
mental condition was used. For the invasion assays, cells that
had traversed to the lower membrane after either 24 h (HeLa cells)
or 48 h (C-33A cells) were counted.
2.13. Knockdown of TNKS2 by siRNA
A plasmid designed to knockdown TNKS2 was constructed, and
the primers: TNKS2-siR-Top 50-GATCCGATACACTCACCGGAGAAAT
TCAAGAGATTTCTCCGGTGAGTGTATCTTTTTTGGAAGAATTCA-30 and
TNKS2-siR-Bot 50-AGCTTGAATTCTTCCAAAAAAGATACACTCACCGGA
GAAATCTCTTGAATTTCTCCGGTGAGTGTATCG-30 were annealed and
inserted into pSilencer 2.1 U6 neo (Ambion, Austin, TX, USA) accord-
ing to the manufacturer’s instructions. The resulting plasmid wastermed pSilencer/sh-TNKS2 (siR-TNKS2). HeLa and C-33A cells
were transfected with siR-TNKS2 and pSilencer-Negative control
vector (siR-control, Ambion, Austin, TX, USA) was used as the con-
trol plasmid.
2.14. Statistical analysis
Data are expressed as the means ± SD. Statistical analyses were
performed using a paired t-test. A P-value <0.05 is considered sta-
tistically signiﬁcant. One representative experiment is shown of
duplicates or triplicates used for the statistical analysis.
3. Results
3.1. miR-20a does not affect cell viability but alters colony formation in
cervical cancer cells
To determine if miR-20a can affect cell viability and growth in
cervical cancer cells, the MTT assay and colony formation assay
were used. Either miR-20a antisense oligonucleotides (ASO-miR-
Fig. 4. miR-20a upregulates TNKS2 expression by binding the 30UTR of TNKS2. (A) The TNKS2 30UTR has a putative miR-20a binding site that is conserved in human, mouse,
rat, chicken, and opossum mRNA. The predicted duplex of miR-20a (middle) and its binding site in the 30UTR of TNKS2 (top) or the mutated 30UTR of TNKS2 (bottom) are
shown. (B) The intensity of EGFP ﬂuorescence in reporter cells transfected with pri-miR-20a was increased after 48 h (P < 0.01). Further, the intensity of EGFP ﬂuorescence in
cells transfected with ASO-miR-20a was decreased (P < 0.01) in HeLa cell. (C) Pri-miR-20a and ASO-miR-20a had no effect on the intensity of EGFP ﬂuorescence when cells
were transfected with the 30UTR mutant vector (P > 0.05) (D). All experiments were performed at least three times.
Fig. 3. Expression of miR-20a and TNKS2 in cervical cancer and normal tissues. The relative expression levels of miR-20a (A) and TNKS2 (B) in 18 paired samples of cervical
cancer tissues and matched normal tissues were detected by quantitative RT–PCR.
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ted into HeLa and C-33A cells, and miR-20a levels were detected by
real-time PCR. We found that the expression level of miR-20a in
cells transfected with pri-miR-20a was upregulated 3.5-fold com-
pared with control groups. In contrast, the expression level of
miR-20a transfected with ASO-miR-20a decreased by almost 85%
in HeLa cells (Fig. 1A). Similar results were obtained in C-33A cells
(Fig. 1B). Results of the MTT assay showed that pri-miR-20a and
ASO-miR-20a did not signiﬁcantly inﬂuence cell viability (Fig. 1C
and D). However, colony formation ability was increased when
miR-20a expression was upregulated and decreased when miR-
20a was inhibited (Fig. 1E and F).3.2. miR-20a promotes migration and invasion of cervical cancer cells
in vitro
To determine if miR-20a can affect the migration and invasion
properties of cells, we transfected HeLa and C-33A cells with
pri-miR-20a and detected changes in their motility using Transwell
assays. Transwell assays performed in the absence of Matrigel
showed that overexpression of miR-20a promoted HeLa cell migra-
tion by 1.3-fold compared to control cells. In contrast, HeLa cell
migration activity was signiﬁcantly inhibited when cells were
transfected by ASO-miR-20a compared to ASO-NC transfected cells
(Fig. 2A). Similar results were obtained using C-33A cells (Fig. 2B).
Fig. 5. MiR-20a affects the mRNA and protein levels of TNKS2. (A and B) In HeLa and C-33A cells, the mRNA level of TNKS2 was signiﬁcantly increased in cells transfected with
pcDNA3/pri-miR-20a, whereas the TNKS2 mRNA levels were obviously decreased when cells were transfected with ASO-miR-20a. (C and D). Altering the levels of miR-20a in
HeLa and C-33A cells has similar effects on the protein levels of TNKS2.
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HeLa cells (Fig. 2C) and C-33A (Fig. 2D) as measured by transwell
assays that included 2 mg/ml Matrigel. Further, a decrease in the
invasion ability of ASO-miR-20a-transfected cells, compared with
ASO-NC-transfected cells, indicated that miR-20a also participated
in human cervical cancer cell invasion (Fig. 2C and D).
3.3. Expression of miR-20a and TNKS2 in cervical cancer and adjacent
normal tissues
Eighteen paired samples of cervical cancer tissue and their adja-
cent normal tissue were analyzed for the expression of miR-20 a
and TNKS2 by quantitative RT–PCR assay. After normalization to
the U6 snRNA control, miR-20a was found to be expressed at sig-
niﬁcantly higher levels in tumor tissues when compared to the cor-
responding non-tumor tissues (Fig. 3A). TNKS2 was also expressed
at signiﬁcantly higher levels in tumor samples when compared to
the corresponding normal tissues after normalization to the b-actin
control (Fig. 3B).
3.4. miR-20a upregulates TNKS2 expression by binding the 30UTR of
TNKS2
We used algorithms, including TargetScan, PicTar, and miRanda,
to predict potential targets for miR-20a. Our results suggested that
TNKS2 could be targeted by miR-20a and this property was con-served between human, mouse, rat, chicken, and opossum mRNA
(Fig. 4A). We constructed EGFP reporter vectors carrying the TNKS2
30UTR or mutant TNKS2 3’UTR downstream of EGFP stop codon
(TNKS2–30UTR or TNKS2–30UTR mut) and performed the EGFP re-
porter assays. The results showed an increased EGFP intensity in
TNKS2–30UTR transfected cells compared with the control group,
whereas transfection of TNKS2–30UTR mut vector abolished the
upregulation of EGFP. These data indicated that endogenous miR-
20a might positively increase TNKS2 expression by binding to its
30UTR (Fig. 4B). Further, enhanced miR-20a levels can signiﬁcantly
increase EGFP expression, whereas blocking miR-20a inhibits EGFP
(Fig. 4C). However, the EGFP expression in cells transfected with
TNKS2–30UTR mut was not affected by different levels of miR-
20a (Fig. 4D). These results suggested that miR-20a could directly
bind to the 30UTR and speciﬁcally promote the expression of
TNKS2.
3.5. miR-20a affects the mRNA and protein level of TNKS2
To determine whether miR-20a affects endogenous TNKS2 pro-
tein levels, TNKS2 mRNA and protein were detected by quantita-
tive RT–PCR and Western blot analysis, respectively. In HeLa and
C-33A cells transfected with pri-miR-20a, TNKS2 mRNA levels
were signiﬁcantly increased. In contrast, mRNA levels were re-
duced when cells were transfected with ASO-miR-20a (Fig. 5A
and B). We also found that increased miR-20a levels can
Fig. 6. Knockdown of TNKS2 suppresses colony formation and the capacities of cells to migrate and invade adjacent tissues in an in vitro Matrigel assay. (A and B) TNKS2
mRNA (A) and protein (B) was detected by quantitative RT–PCR and Western blot assay, respectively, following siR-TNKS2 transfection. The results showed a signiﬁcantly
reduced level of both TNKS2 mRNA and protein in HeLa and C-33A cells. (C) The MTT assay showed that knockdown of TNKS2 did not affect cell viability of HeLa or C-33A
cells in the short-term. (D) The colony formation assay revealed that the average colony formation number was reduced following TNKS2 knockdown. (E and F) Cell migration
(E) and invasion (F) were decreased by knockdown of TNKS2 in HeLa and C-33A cells.
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levels of miR-20a inhibit the protein expression of TNKS2 (Fig. 5C
and D). These data revealed that miR-20a can positively regulate
TNKS2 mRNA and protein expression.
3.6. Knockdown of TNKS2 suppresses cell colony formation, migration
and invasion in vitro
The function of TNKS2 in HeLa and C-33A cells was examined
using RNA interference. The results showed that mRNA and protein
levels decreased when siR-TNKS2 was transfected into HeLa or C-
33A cells (Fig. 6A and B). Further more, while inhibition of TNKS2
does not affect cell viability in short-term cultures (Fig. 6C), it
can suppress the ability of cells to form colonies (Fig. 6D), migrate
(Fig. 6E) and invade adjacent tissues (Fig. 6F).
4. Discussion
Here we show that miR-20a is upregulated in cervical cancer,
thereby suggesting that the high level of miR-20a may be related
to the malignant phenotype of cervical cancer. To further under-
stand this process, we examined the effect of miR-20a overexpres-
sion in HeLa and C-33A cells and found enhanced colony formation
and cellular invasion and migration, but no effect on short-term
cell viability. Further, ASO-miR-20a, an antisense oligonucleotide,
had the opposite effect from miR-20a in HeLa and C-33A cells.
Identiﬁcation of cancer speciﬁc miRNAs and their targets is crit-
ical for understanding their role in tumorigenesis [9,17,18]. Several
studies have revealed that miRNAs either prevent translation or
promote the degradation of speciﬁc targets by binding to the30UTRs of target mRNAs [19]. However, an emerging assortment
of studies has revealed that miRNAs can function to post-transcrip-
tionally stimulate gene expression by direct mechanisms, a process
termed activation [20]. For instance, miR-145 upregulates myocar-
din during muscle differentiation [21]. Likewise, KLF4 mRNA was
upregulated by miR-206 in conﬂuent cells and non-cancerous cells,
but was downregulated by miR-206 or miR-344 in proliferating
cancer cells [22]. Therefore, miRNA-mediated upregulation is tar-
get speciﬁc and dependent on the conditions of the distinct target
mRNAs. In our study, the TNKS2 transcript was predicted to have
an miR-20a binding site, and the EGFP ﬂuorescence intensity of
EGFP-TNKS2–30UTR was speciﬁcally responsive to miR-20a overex-
pression in reporter assays. A mutation in the miR-20a binding site
abolished the effect of miR-20a on the regulation of EGFP ﬂuores-
cence intensity. Moreover, we observed a positive correlation be-
tween the expression of miR-20a and TNKS2 in tumor tissues
and corresponding normal cervix uteri tissues by quantitative
RT–PCR. Finally, endogenous TNKS2 expression, both mRNA and
protein, was increased in HeLa and C-33A cells transfected with
pri-miR-20a, but decreased in HeLa and C-33A cells transfected
with ASO-miR-20a. Together, these data suggest that miR-20a
modulates the translation of TNKS2 mRNA via binding sites in its
30UTR and promotes the expression of TNKS2 mRNA and protein
in HeLa and C-33A cells.
The maintenance of telomeric DNA is required for long-term
proliferation of eukaryotic cells and the continuous growth of tu-
mor cells, and telomere integrity is essential for chromosome sta-
bility [14]. TNKS2 is responsible for the protection of the ends of
linear chromosomes [14]. TNKS2 was also recently identiﬁed as
an auto-antigen in several cancer patients, and abnormal levels
904 H.-W. Kang et al. / FEBS Letters 586 (2012) 897–904or its modiﬁcation may contribute to immune responses in cancer
patients [23,24]. Here we found that colony formation, cellular
invasion and migration of HeLa and C-33A cells was inhibited
when TNKS2 was knocked down. Taken together with our data
showing that TNKS2 was upregulated in cervical cancer tissues,
we propose that TNKS2 functions as an oncogene in cervical
cancer.
In summary, we demonstrated that miR-20a and TNKS2 expres-
sion are both upregulated in cervical cancer tissues. The function of
miR-20a in promoting colony formation, cellular invasion and
migration in human cervical cancer cells is, at least in part, through
the upregulation of TNKS2 mRNA and protein levels. Indeed, these
results conﬁrm a correlation between miR-20a and TNKS2, and
they help us to understand the potential molecular mechanism
of cervical carcinogenesis, which may provide new clues for the
therapy of cervical cancer in the future.
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